Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

DPA shows comparable chemotherapy sensitizing effects as EPA upon cellular incorporation in tumor cells.

Dijk FJ, van Dijk M, Dorresteijn B, van Norren K.

Oncotarget. 2019 Oct 15;10(57):5983-5992. doi: 10.18632/oncotarget.27236. eCollection 2019 Oct 15.

2.

Trajectory of body mass and skeletal muscle indices and disease progression in metastatic colorectal cancer patients.

Kurk SA, Stellato RK, Peeters PHM, Dorresteijn B, Jourdan M, Oskam MJ, Punt CJA, Koopman M, May AM.

Am J Clin Nutr. 2019 Sep 12. pii: nqz209. doi: 10.1093/ajcn/nqz209. [Epub ahead of print]

PMID:
31515555
3.

Skeletal muscle mass loss and dose-limiting toxicities in metastatic colorectal cancer patients.

Kurk S, Peeters P, Stellato R, Dorresteijn B, de Jong P, Jourdan M, Creemers GJ, Erdkamp F, de Jongh F, Kint P, Simkens L, Tanis B, Tjin-A-Ton M, Van Der Velden A, Punt C, Koopman M, May A.

J Cachexia Sarcopenia Muscle. 2019 Aug;10(4):803-813. doi: 10.1002/jcsm.12436. Epub 2019 May 15.

4.

Impact of different palliative systemic treatments on skeletal muscle mass in metastatic colorectal cancer patients.

Kurk SA, Peeters PHM, Dorresteijn B, de Jong PA, Jourdan M, Kuijf HJ, Punt CJA, Koopman M, May AM.

J Cachexia Sarcopenia Muscle. 2018 Oct;9(5):909-919. doi: 10.1002/jcsm.12337. Epub 2018 Aug 24.

5.

Extremely thin layer plastification for focused-ion beam scanning electron microscopy: an improved method to study cell surfaces and organelles of cultured cells.

VAN Donselaar EG, Dorresteijn B, Popov-Čeleketić D, VAN DE Wetering WJ, Verrips TC, Boekhout T, Schneijdenberg CTWM, Xenaki AT, VAN DER Krift TP, Müller WH.

J Microsc. 2018 Jun;270(3):359-373. doi: 10.1111/jmi.12694. Epub 2018 Mar 25.

PMID:
29574724
6.

A novel immuno-gold labeling protocol for nanobody-based detection of HER2 in breast cancer cells using immuno-electron microscopy.

Kijanka M, van Donselaar EG, Müller WH, Dorresteijn B, Popov-Čeleketić D, El Khattabi M, Verrips CT, van Bergen En Henegouwen PMP, Post JA.

J Struct Biol. 2017 Jul;199(1):1-11. doi: 10.1016/j.jsb.2017.05.008. Epub 2017 May 25.

7.

Hypoxia-Targeting Fluorescent Nanobodies for Optical Molecular Imaging of Pre-Invasive Breast Cancer.

van Brussel AS, Adams A, Oliveira S, Dorresteijn B, El Khattabi M, Vermeulen JF, van der Wall E, Mali WP, Derksen PW, van Diest PJ, van Bergen En Henegouwen PM.

Mol Imaging Biol. 2016 Aug;18(4):535-44. doi: 10.1007/s11307-015-0909-6.

8.

Camelid heavy chain only antibody fragment domain against β-site of amyloid precursor protein cleaving enzyme 1 inhibits β-secretase activity in vitro and in vivo.

Dorresteijn B, Rotman M, Faber D, Schravesande R, Suidgeest E, van der Weerd L, van der Maarel SM, Verrips CT, El Khattabi M.

FEBS J. 2015 Sep;282(18):3618-31. doi: 10.1111/febs.13367. Epub 2015 Jul 22.

9.

Nanobody-based cancer therapy of solid tumors.

Kijanka M, Dorresteijn B, Oliveira S, van Bergen en Henegouwen PM.

Nanomedicine (Lond). 2015 Jan;10(1):161-74. doi: 10.2217/nnm.14.178. Review.

10.

Etiological role of viruses in outbreaks of acute gastroenteritis in The Netherlands from 1994 through 2005.

Svraka S, Duizer E, Vennema H, de Bruin E, van der Veer B, Dorresteijn B, Koopmans M.

J Clin Microbiol. 2007 May;45(5):1389-94. Epub 2007 Mar 14.

Supplemental Content

Loading ...
Support Center